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Background
There are clear clinical drivers for right ventricular (RV)
T1 mapping in patients with repaired tetralogy of Fallot
(rTOF), in whom myocardial fibrosis is implicated in
adverse clinical outcomes. However, considerable tech-
nical challenges exist, due to thin mobile RV wall with
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Figure 1 Representative short-axis images from subjects scanned for RV T1 mapping by fat-water separated, MSPrep dark blood
imaging. Images for five subjects with repaired tetralogy of Fallot and five healthy volunteers shown (one subject per column): Top row - MoCo
averaged water-only image at Ts 600 ms, Second row - MoCo averaged water-only anchor image at same window/level, Third row - MoCo
averaged fat only image, Bottom row - T1 map generated from registration and 2-parameter fit of the six images per sampling scheme.
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adjacent strong signals from blood and epicardial fat.
We prospectively aimed to explore the possible clinical




We adopted a saturation recovery (SASHA) based
approach with MoCo averaging of single-shot fat-water
separated images at 1.5T (Siemens Avanto, 32-channel
thoracic phased-array).4 We applied Motion-sensitive
dephasing (MSPrep) to null blood signal before each
shot.1-3 Composite saturation and MSPrep parameters
were optimised prior to four 10-cycle scans at satura-
tion-recovery delay Ts≈600 ms and two “anchor” scans
at Ts>6 sec,5 run free-breathing twice pre-contrast
administration (Figure 1). Complex non-rigid MoCo
averaging6 (fixed 50% acceptance) incorporated 5 shots
at the most similar respiratory phase. Imaging para-
meters: TE = 1.0,2.7,4.3 ms (reduced to tolerate proxi-
mity to sternal wires), FA 10°, 6 × 1.9 × 2.1 mm
acquired voxels, TGRAPPA rate 4, diastolic shot
Figure 2 Study subject demographics and T1 mapping results reported as mean ± standard deviation (SD). Note that MOLLI was used
for LV values as the new method was targeted on the RV wall. ECV: extracellular volume fraction, EDVi: indexed end-diastolic volume, ESVi:
indexed end-systolic volume, SVi: indexed stroke volume, EF: ejection fraction, LAAi: indexed left atrial area, LV: left ventricle, Mi: indexed mass,
RAAi: indexed right atrial area, rTOF: repaired tetralogy of Fallot, RV: right ventricle
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duration 175 ms. Post-contrast (0.15 mmol/kg Gadovist)
RV T1 scans used Ts≈200 ms and “anchor” Ts>3 sec.
Separate 11-HB MOLLIs were acquired for blood T1
and LV ECV, at a LV-aligned short-axis plane pre-con-
trast (5(3)3) and 15 minutes post-contrast (4(1)3(1)2).7
Clinical
Data for 22 subjects (11 patients with rTOF and 11 age
and gender-matched healthy volunteers) were acquired.
Two-parameter fit pixelwise T1 maps were generated
for each run. Mean RV free wall T1s were measured
by two independent observers using CMR42. Inter-
observer reproducibility was calculated by coefficient
of variation (CoV%) = (within-subject standard devia-
tion/mean) x100%.
Results
RV T1 maps were obtained in all subjects, with inter-
observer reproducibility of native RV myocardial T1
(CoV 1.8%) and RV ECV (CoV 6.8%). There was no sig-
nificant difference in RV native T1 and ECV of patients
with rTOF compared to the controls who had thin RV
wallls (Figure 2). This may reflect the modest sample
size, or the inclusion of clinically stable patients with
rTOF with minimal residual haemodynamic lesions, or
may also reflect technical limitations. Saturation was
optimised to <1% in the RV but non-uniformity over
the heart requires investigation. The MSPrep required
subject-specific optimisation for minimal partial volume
contamination by blood which may explain high RV
ECV. Known underestimation of native T1 by MOLLI
compared to SASHA may also explain some of the
RV-LV difference.
Conclusions
RV T1 and ECV quantification is possible with the pro-
posed technique but requires further development. The
diagnostic value in this patient population merits further
work towards a larger study and to explore histological
correlation.
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